FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W96058809> ?p ?o ?g. }

• W96058809 endingPage "1017" @default.
• W96058809 startingPage "1011" @default.
• W96058809 abstract "The clinical use of prostate specific antigen as a screening test for prostate cancer, as a preoperative determinant for staging of prostate cancer and to monitor response to therapy in prostatic cancer patients was evaluated in 168 men with benign prostatic hyperplasia and 231 men with prostate cancer. Only 3% of the men with benign prostatic hyperplasia had prostate specific antigen levels greater than 10 ng. per ml. compared to 44% of the men with proved prostate cancer. Preoperative prostate specific antigen levels increased with higher clinical stages of prostate cancer but there was substantial overlap among stages. Among patients with stage A1 prostate cancer who were followed expectantly none had an elevated prostate specific antigen value or metastatic disease during a followup of 15 to 120 months. After radical prostatectomy serum prostate specific antigen values decreased to undetectable levels (less than 0.6 ng. per ml.) in 89% of the patients with organ-confined disease, in 87% of those with microscopically positive margins only but in only 34% with seminal vesicles or lymph node involvement. Failure of the prostate specific antigen levels to decrease to the undetectable range after radical prostatectomy was associated with a greater likelihood of subsequent tumor recurrence. Only 3 of 18 patients (17%) treated with definitive radiation therapy had post-irradiation prostate specific antigen values of less than 0.6 ng. per ml., while in 39% the prostate specific antigens values remained greater than 4 ng. per ml. and in 4 of 18 (22%) the values were greater than 10 ng. per ml. Of patients with previously untreated stage D2 prostate cancer the mean pre-treatment prostate specific antigen value was 63.7 ng. per ml. compared to a post-hormonal therapy mean value of 31.1 ng. per ml. Of 32 patients treated with hormonal therapy 14 had stable disease, including 13 with prostate specific antigen levels of less than 10 ng. per ml. In contrast, 18 patients had progressive disease, of whom 16 had prostate specific antigen levels of more than 10 ng. per ml. We conclude that the serum prostate specific antigen assay is most useful clinically to monitor the response to therapy of prostate cancer patients." @default.
• W96058809 created "2016-06-24" @default.
• W96058809 creator A5040907593 @default.
• W96058809 creator A5060306938 @default.
• W96058809 creator A5065869555 @default.
• W96058809 date "1989-10-01" @default.
• W96058809 modified "2023-10-17" @default.
• W96058809 title "Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer" @default.
• W96058809 cites W108292446 @default.
• W96058809 cites W166500613 @default.
• W96058809 cites W1945252083 @default.
• W96058809 cites W1997492763 @default.
• W96058809 cites W2002538042 @default.
• W96058809 cites W2027925208 @default.
• W96058809 cites W2060714317 @default.
• W96058809 cites W2061734101 @default.
• W96058809 cites W2064180812 @default.
• W96058809 cites W2257146860 @default.
• W96058809 cites W2330292521 @default.
• W96058809 cites W38427941 @default.
• W96058809 cites W4239537387 @default.
• W96058809 cites W53877061 @default.
• W96058809 doi "https://doi.org/10.1016/s0022-5347(17)38972-3" @default.
• W96058809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2477559" @default.
• W96058809 hasPublicationYear "1989" @default.
• W96058809 type Work @default.
• W96058809 sameAs 96058809 @default.
• W96058809 citedByCount "472" @default.
• W96058809 countsByYear W960588092012 @default.
• W96058809 countsByYear W960588092013 @default.
• W96058809 countsByYear W960588092014 @default.
• W96058809 countsByYear W960588092015 @default.
• W96058809 countsByYear W960588092016 @default.
• W96058809 countsByYear W960588092017 @default.
• W96058809 countsByYear W960588092018 @default.
• W96058809 countsByYear W960588092020 @default.
• W96058809 countsByYear W960588092021 @default.
• W96058809 countsByYear W960588092022 @default.
• W96058809 countsByYear W960588092023 @default.
• W96058809 crossrefType "journal-article" @default.
• W96058809 hasAuthorship W96058809A5040907593 @default.
• W96058809 hasAuthorship W96058809A5060306938 @default.
• W96058809 hasAuthorship W96058809A5065869555 @default.
• W96058809 hasConcept C121608353 @default.
• W96058809 hasConcept C126322002 @default.
• W96058809 hasConcept C126894567 @default.
• W96058809 hasConcept C143998085 @default.
• W96058809 hasConcept C147483822 @default.
• W96058809 hasConcept C203014093 @default.
• W96058809 hasConcept C2776235491 @default.
• W96058809 hasConcept C2777562237 @default.
• W96058809 hasConcept C2779466945 @default.
• W96058809 hasConcept C2780192828 @default.
• W96058809 hasConcept C2781406297 @default.
• W96058809 hasConcept C71924100 @default.
• W96058809 hasConcept C87874733 @default.
• W96058809 hasConceptScore W96058809C121608353 @default.
• W96058809 hasConceptScore W96058809C126322002 @default.
• W96058809 hasConceptScore W96058809C126894567 @default.
• W96058809 hasConceptScore W96058809C143998085 @default.
• W96058809 hasConceptScore W96058809C147483822 @default.
• W96058809 hasConceptScore W96058809C203014093 @default.
• W96058809 hasConceptScore W96058809C2776235491 @default.
• W96058809 hasConceptScore W96058809C2777562237 @default.
• W96058809 hasConceptScore W96058809C2779466945 @default.
• W96058809 hasConceptScore W96058809C2780192828 @default.
• W96058809 hasConceptScore W96058809C2781406297 @default.
• W96058809 hasConceptScore W96058809C71924100 @default.
• W96058809 hasConceptScore W96058809C87874733 @default.
• W96058809 hasIssue "4" @default.
• W96058809 hasLocation W960588091 @default.
• W96058809 hasLocation W960588092 @default.
• W96058809 hasOpenAccess W96058809 @default.
• W96058809 hasPrimaryLocation W960588091 @default.
• W96058809 hasRelatedWork W1979901203 @default.
• W96058809 hasRelatedWork W1979955543 @default.
• W96058809 hasRelatedWork W1982816235 @default.
• W96058809 hasRelatedWork W2060445317 @default.
• W96058809 hasRelatedWork W2111952090 @default.
• W96058809 hasRelatedWork W2132116871 @default.
• W96058809 hasRelatedWork W2143699516 @default.
• W96058809 hasRelatedWork W2354678759 @default.
• W96058809 hasRelatedWork W2390799543 @default.
• W96058809 hasRelatedWork W93186087 @default.
• W96058809 hasVolume "142" @default.
• W96058809 isParatext "false" @default.
• W96058809 isRetracted "false" @default.
• W96058809 magId "96058809" @default.
• W96058809 workType "article" @default.